Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interviews

Interview: Artem Sirazutdinov, Sistema and Medsi

By any measure, Sistema backed Russian healthcare network Medsi is doing rather well. Its most recent financial reports saw H2 revenue growth of over 40%, and the company continues to grow geographically. HBI caught up with Artem Sirazutdinov, chairman of the Medsi Board of Directors and a managing partner at Sistema, to find out more.

Interview: Dr Volker Wendel, Sanoptis CEO

How do you build a €100m European ophthalmology group without attracting headlines? HBI speaks to the CEO of the new kid on the block Sanoptis, which has a significant presence now in German and Switzerland, to find out why it has been deliberately operating under the radar – and how it’s managed to quietly build a €100m business in the space of a year.

Interview: Dave Mezher, CEO, The Doctors Clinic Group

The Doctors Clinic Group, set up in 2014 with the aim of delivering convenient and affordable access to London GPs, is expanding rapidly. HBI talks to CEO Dave Mezher to find out more.

Interview: Julian Andriesz, CEO, Verita Healthcare

The massive latent demand to live longer is being tapped by a new generation of health care providers. British entrepreneur Julian Andriesz, 53, made a first fortune building business in SE Asia and got into prevention after watching his mother die of ovarian cancer, diagnosed late. He says his intention is to help his clients, whether they are healthy, have cancer or auto-immune diseases, to live longer, better lives. Verita has a chain of 10 clinics, believes its digital health disease prevention and management platform is about to become the largest in the world and owns IP, and research and manufacturing in Europe, Asia and Australia.

Interview: Vasco Antunes Pereira, CEO, Lusiadas Saude

We talk to the CEO of UnitedHealth Group-owned Lusiadas Saude, Portugal’s third-largest private hospital group and the only one whose facilities have had their electronic health record technology rubber-stamped by HIMSS, the largest health IT organisation in the world. He explains what that actually means for delivering acute healthcare services.

Interview: Dr Jacob Thomas, chairman of Ramsay Sime Darby

The underbidder for Columbia Asia's South and SE Asia's hospital chain which had a $2bn price tag, Ramsay Sime Darby brought together Ramsay's three hospitals in Indonesia with Sime Darby's three in Malaysia in 2013.  We talk to Dr Thomas about offering spare capacity to the public sector at a discounted rate, progress with large-scale PPPs, regulations, medical tourism and expansion plans.

Interview: Tony Romero, CEO, Cygnet Healthcare

The UK psychiatry and disabled care markets are facing many challenges - the uncertainty of Brexit, an unstable pound, and scandals at The Priory have all taken their toll. We interview CEO of Cygnet Healthcare, Tony Romero, on the biggest issues facing the market and what future he sees for a sector where two of the biggest players could both soon be on the block.

Interview: Peter Graf, CEO, Tiohundra

Uniquely, we think in Europe, Tiohundra, an organisation serving a municipality of 62,000, has fully merged social care and health care delivery. Social care (elderly care, disabled care, homecare, psychiatry) and health care (hospitals and primary care) – have been melded in to a single organisation. So what are the learnings? And are we going […]

Interview: Ray Berglund, Managing Director, Alvarez & Marsal European Healthcare industry practice

We talk to consultancy Alvarez & Marsal's (A&M) recently-appointed head of European Healthcare & Life Sciences industry practice, medtech specialist Ray Berglund, about the sector's move into healthcare services.

Interview: Tim Clover, CEO, Rayner

HBI talks to Tim Clover, CEO of ophthalmology medtech supplier Rayner and former CEO of ophthalmology operator Optegra about his take on the market, challenges and opportunities in the future, and plans for the company going forward, including coming to market in the next two years - or sooner.

Find Us